Didier Coquoz
CEO
Copexis
Switzerland
Biography
Didier Coquoz, PhD in clinical pharmacology, is a 20+ years seasoned pharma R&D executive (VP R&D and CEO). He has been instrumental in the development/regulatory management from drug candidate up to phase III and registration of close to 30 biologics, monoclonal antibodies, peptides, cell-based therapeutics, NCEs, of which 4 reached the market world-wide. He held positions as CEO and VP R&D on both sides of the Atlantic. He currently acts through Copexis S.A. as Chief Development Officer, Chief Regulatory Affairs and Chief Business Development Affairs for different biotechs/mid pharmas in Europe, mostly in immunology.
Research Interest
Monoclonal antibodies, peptides, cell-based therapeutics